Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 16, 2012, Pages 6271-6276

  Quednow, Boris B ^a,b   Brinkmeyer, Jur̈gen ^c,d   Mobascher, Arian ^c,d,e   Nothnagel, Michael ^f   Musso, Francesco ^c   Grun̈der, Gerhard ^g   Savary, Noah ^a   Petrovsky, Nadine ^b   Frommann, Ingo ^b   Lennertz, Leonhard ^b   Spreckelmeyer, Katja N ^g   Wienker, Thomas F ^b   Dahmen, Norbert ^e   Thuerauf, Norbert ^h   Clepce, Marion ^h   Kiefer, Falk ⁱ   Majic, Tomislav ^j   Mos̈sner, Rainald ^a   Maier, Wolfgang ^b,k   Gallinat, Jur̈gen ^j   Diaz Lacava, Amalia ^l   Toliat, Mohammad R ^l   Thiele, Holger ^l   Nur̈nberg, Peter ^l   Wagner, Michael ^b,k   Winterer, Georg ^d,l   more..

^a UNIVERSITY HOSPITAL OF PSYCHIATRY ZURICH   (Switzerland)

^b UNIVERSITY OF BONN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g RWTH AACHEN UNIVERSITY   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^l UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Gene environment interaction; Intermediate phenotype; Nicotine; Single nucleotide polymorphism

Indexed keywords

CARBON MONOXIDE; COTININE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG;

ARTICLE; AUDITORY SENSORY GATING; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EXPIRED AIR; FAGERSTROM TEST; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SENSORY GATING; SMOKING; SMOKING HABIT;

ADULT; ANALYSIS OF VARIANCE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; COTININE; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; GENE FREQUENCY; GENOTYPE; GEOGRAPHY; GERMANY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA; SENSORY GATING; SMOKING; TRANSCRIPTION FACTORS;

EID: 84859931472     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1118051109     Document Type: Article

References (81)

1. Ripke S, et al.; Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43:969-976.
2. Stefansson H, et al.; Genetic Risk and Outcome in Psychosis (GROUP) (2009) Common variants conferring risk of schizophrenia. Nature 460:744-747.
3. Steinberg S, et al.; Irish Schizophrenia Genomics Consortium; GROUP; Wellcome Trust Case Control Consortium 2 (2011) Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 20:4076-4081.
4. Flora A, Garcia JJ, Thaller C, Zoghbi HY (2007) The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci USA 104:15382-15387. (Pubitemid 47502926)
5. Ross SE, Greenberg ME, Stiles CD (2003) Basic helix-loop-helix factors in cortical development. Neuron 39:13-25. (Pubitemid 36830945)
6. de Pontual L, et al. (2009) Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 30:669-676.
7. Williams HJ, et al. (2011) Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis-acting regulation of mRNA expression in adult human brain. Am J Med Genet B Neuropsychiatr Genet 156B:781-784.
8. Brzózka MM, Radyushkin K, Wichert SP, Ehrenreich H, Rossner MJ (2010) Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 68:33-40.
9. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160:636-645. (Pubitemid 41079594)
10. Quednow BB, et al. (2011) The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci 31:6684-6691.
11. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD (1983) Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biol Psychiatry 18:537-551. (Pubitemid 13135325)
12. Grunwald T, et al. (2003) Neuronal substrates of sensory gating within the human brain. Biol Psychiatry 53:511-519. (Pubitemid 36331890)
13. Korzyukov O, et al. (2007) Generators of the intracranial P50 response in auditory sensory gating. Neuroimage 35:814-826. (Pubitemid 46420427)
14. Bak N, Glenthoj BY, Rostrup E, Larsson HB, Oranje B (2011) Source localization of sensory gating: A combined EEG and fMRI study in healthy volunteers. Neuroimage 54:2711-2718.
15. Braff DL, Light GA (2004) Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) 174:75-85. (Pubitemid 38925093)
16. Lijffijt M, et al. (2009) P50, N100, and P200 sensory gating: Relationships with behavioral inhibition, attention, and working memory. Psychophysiology 46: 1059-1068.
17. Wan L, Friedman BH, Boutros NN, Crawford HJ (2008) P50 sensory gating and attentional performance. Int J Psychophysiol 67:91-100. (Pubitemid 351163416)
18. Yadon CA, Bugg JM, Kisley MA, Davalos DB (2009) P50 sensory gating is related to performance on select tasks of cognitive inhibition. Cogn Affect Behav Neurosci 9: 448-458.
19. Thomas C, et al. (2010) P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function. Neurobiol Aging 31:416-424.
20. Adler LE, et al. (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639-654. (Pubitemid 12090209)
21. Clementz BA, Geyer MA, Braff DL (1997) P50 suppression among schizophrenia and normal comparison subjects: A methodological analysis. Biol Psychiatry 41:1035-1044. (Pubitemid 27225991)
22. Erwin RJ, Turetsky BI, Moberg P, Gur RC, Gur RE (1998) P50 abnormalities in schizophrenia: Relationship to clinical and neuropsychological indices of attention. Schizophr Res 33:157-167. (Pubitemid 28446540)
23. Judd LL, McAdams L, Budnick B, Braff DL (1992) Sensory gating deficits in schizophrenia: New results. Am J Psychiatry 149:488-493.
24. Nagamoto HT, Adler LE, Waldo MC, Griffith J, Freedman R (1991) Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schizophr Res 4:31-40.
25. Yee CM, Nuechterlein KH, Morris SE, White PM (1998) P50 suppression in recent-onset schizophrenia: Clinical correlates and risperidone effects. J AbnormPsychol 107:691-698. (Pubitemid 28527584)
26. Arnfred SM, Chen AC, Glenthøj BY, Hemmingsen RP (2003) Normal p50 gating in unmedicated schizophrenia outpatients. Am J Psychiatry 160:2236-2238. (Pubitemid 39619621)
27. Guterman Y, Josiassen RC (1994) Sensory gating deviance in schizophrenia in the context of task related effects. Int J Psychophysiol 18:1-12. (Pubitemid 24344511)
28. Jin Y, et al. (1998) Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry 43:873-878. (Pubitemid 28288365)
29. Kathmann N, Engel RR (1990) Sensory gating in normals and schizophrenics: A failure to find strong P50 suppression in normals. Biol Psychiatry 27:1216-1226. (Pubitemid 20157935)
30. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S (2004) Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 70:315-329. (Pubitemid 39141109)
31. de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Linszen DH (2007) A meta-analysis of P50 studies in patients with schizophrenia and relatives: Differences in methodology between research groups. Schizophr Res 97:137-151. (Pubitemid 350088378)
32. Patterson JV, et al. (2008) P50 sensory gating ratios in schizophrenics and controls: A review and data analysis. Psychiatry Res 158:226-247.
33. Anokhin AP, Vedeniapin AB, Heath AC, Korzyukov O, Boutros NN (2007) Genetic and environmental influences on sensory gating of mid-latency auditory evoked responses: A twin study. Schizophr Res 89:312-319. (Pubitemid 44881286)
34. Greenwood TA, et al. (2007) Initial heritability analyses of endophenotypic measures for schizophrenia: The consortium on the genetics of schizophrenia. Arch Gen Psychiatry 64:1242-1250. (Pubitemid 350074822)
35. Young DA, Waldo M, Rutledge JH, 3rd, Freedman R (1996) Heritability of inhibitory gating of the P50 auditory-evoked potential in monozygotic and dizygotic twins. Neuropsychobiology 33:113-117. (Pubitemid 26156185)
36. Clementz BA, Geyer MA, Braff DL (1998) Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 155:1691-1694. (Pubitemid 28547492)
37. Siegel C, Waldo M, Mizner G, Adler LE, Freedman R (1984) Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry 41:607-612. (Pubitemid 14111389)
38. Cadenhead KS, Light GA, Geyer MA, Braff DL (2000) Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 157:55-59. (Pubitemid 30027421)
39. Brockhaus-Dumke A, et al. (2008) Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 64:376-384.
40. Cadenhead KS, Light GA, Shafer KM, Braff DL (2005) P50 suppression in individuals at risk for schizophrenia: The convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 57:1504-1509. (Pubitemid 40805379)
41. Freedman R, et al. (2003) The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep 5:155-161. (Pubitemid 38899215)
42. Lu BY, et al. (2007) Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia. Biol Psychiatry 62:822-825. (Pubitemid 47374646)
43. Majic T, et al. (2011) COMT Val108/158Met genotype modulates human sensory gating. Neuroimage 55:818-824.
44. Shaikh M, et al. (2011) Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? Psychol Med 41:263-276.
45. Greenwood TA, et al. (2011) Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 168:930-946.
46. Braff DL (2011) Gating in schizophrenia: From genes to cognition (to real world function?). Biol Psychiatry 69:395-396.
47. Braff DL, Light GA, Swerdlow NR (2007) Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry 61: 1204-1207. (Pubitemid 46669461)
48. Oranje B, Geyer MA, Bocker KB, Leon Kenemans J, Verbaten MN (2006) Prepulse inhibition and P50 suppression: Commonalities and dissociations. Psychiatry Res 143:147-158. (Pubitemid 44301523)
49. Schwarzkopf SB, Lamberti JS, Smith DA (1993) Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 33:815-828. (Pubitemid 23234633)
50. Hong LE, Wonodi I, Stine OC, Mitchell BD, Thaker GK (2008) Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry 63:17-23. (Pubitemid 350234892)
51. Roussos P, Giakoumaki SG, Adamaki E, Bitsios P (2011) The influence of schizophreniarelated neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol Psychiatry 69:479-486.
52. Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818-827. (Pubitemid 44435264)
53. Brinkmeyer J, et al. (2011) P50 sensory gating and smoking in the general population. Addict Biol 16:485-498.
54. Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. Am J Psychiatry 155:1490-1501. (Pubitemid 28512015)
55. Zweier C, et al. (2007) Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80:994-1001. (Pubitemid 46668469)
56. Uittenbogaard M, Chiaramello A (2000) Differential expression patterns of the basic helix-loop-helix transcription factors during aging of the murine brain. Neurosci Lett 280:95-98. (Pubitemid 30109141)
57. Zhuang Y, Cheng P, Weintraub H (1996) B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol 16:2898-2905. (Pubitemid 26161295)
58. Xiao R, Boehnke M (2009) Quantifying and correcting for the winner's curse in genetic association studies. Genet Epidemiol 33:453-462.
59. Quednow BB, et al. (2006) Attenuation of the prepulse inhibition of the acoustic startle response within and between sessions. Biol Psychol 71:256-263. (Pubitemid 43220622)
60. Williams TJ, Nuechterlein KH, Subotnik KL, Yee CM (2011) Distinct neural generators of sensory gating in schizophrenia. Psychophysiology 48:470-478.
61. Bierut LJ, et al. (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163-1171.
62. Berrettini W, et al. (2008) Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13:368-373. (Pubitemid 351399826)
63. Liu JZ, et al.; Wellcome Trust Case Control Consortium (2010) Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42:436-440.
64. Petrovsky N, et al. (2010) Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology 35: 1429-1439.
65. Winterer G, et al. (2010) Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet 153B:1448-1458.
66. Greenbaum L, et al. (2006) Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry 11:312-322.
67. Saccone NL, et al. (2010) Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. Genes Brain Behav 9:741-750.
68. Schadt EE, et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6:e107.
69. Alkondon M, Pereira EF, Almeida LE, Randall WR, Albuquerque EX (2000) Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 39: 2726-2739.
70. Besson M, et al. (2007) Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci USA 104:8155-8160. (Pubitemid 47185891)
71. Breese CR, et al. (2000) Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23:351-364.
72. Picciotto MR, et al. (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: Physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92:89-108. (Pubitemid 34251128)
73. Barik J, Wonnacott S (2006) Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: Interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol Pharmacol 69:618-628. (Pubitemid 43121959)
74. Satta R, et al. (2008) Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci USA 105:16356-16361.
75. Philibert RA, et al. (2010) The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. Am J Med Genet B Neuropsychiatr Genet 153:619-628.
76. Lao O, et al. (2008) Correlation between genetic and geographic structure in Europe. Curr Biol 18:1241-1248.
77. Rossler W, Hengartner MP, Angst J, Ajdacic-Gross V (2012) Linking substance use with symptoms of sub-clinical psychosis in a community cohort over 30 years. Addiction, in press.
78. Weiser M, et al. (2004) Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: A historical-prospective cohort study. Am J Psychiatry 161: 1219-1223. (Pubitemid 38859171)
79. Lindenberg A, et al. (2011) The German multi-centre study on smoking-related behavior-description of a population-based case-control study. Addict Biol 16:638-653.
80. Adler LE, et al. (1998) Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24:189-202. (Pubitemid 28404980)
81. Clementz BA, Geyer MA, Braff DL (1998) Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res 30:71-80. (Pubitemid 28097252)